A Comparative Study of the Burn Wound Healing Properties of Saline-Soaked Dressing and Silver Sulfadiazine in Rats

Indian Journal of Surgery

Volumn 73, Issue 1, 2011, Pages 24-27

  Maghsoudi, Hemmat ^a,b   Monshizadeh, Siavash ^a   Mesgari, Mehran ^a  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Burn wounds care; Saline soaked dressing; Silver sulfadiazine

Indexed keywords

EID: 79952042128     PISSN: 09722068     EISSN: 09739793     Source Type: Journal    
DOI: 10.1007/s12262-010-0169-2     Document Type: Article

References (29)

1. Salas Campos L, Fernandes Mansilla M, Martinez de la Chica AM (2005) Topical chemotherapy for the treatment of burns. Rev Enferm 28(5): 67-70.
2. Fraser JF, Cuttle L, Kempf M, Kimble RM (2004) Cytotoxicity of topical antimicrobial agents used in burn wounds in Australasia. ANZ J Surg 74(3): 139-212.
3. Cho Lee AR, Leem H, Lee J, Park KC (2005) Reversal of silver sulfadiazine-impaired wound healing by epidermal growth factor. Biomaterials 26(22): 4670-6.
4. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ (2005) In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In Vitro 19(7): 975-83.
5. Braydich-Stolle L, Hussain S, Schlager JJ, Hofmann MC (2005) In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 88(2): 412-9.
6. Lam PK, Chan ES, Ho WS, Liew CT (2004) In vitro cytotoxicity testing of a nanocrystalline silver dressing (Acticoat) on cultured keratinocytes. Br J Biomed Sci 61(3): 125-7.
7. Walker HL, Mason AD (1968) A standard animal burn. J Trauma 8: 1049-51.
8. Fox C (1968) Silver sulfadiazine, a new topical therapy for Pseudomonas in burns. Arch Surg 19: 184.
9. Gilman and Goodman (1975) Pharmacologic basis of therapeutics, 5th edn. McMullin, NY, p 930.
10. Warriner R, Burrell R (2005) Infection and the chronic wound: a focus on silver. Adv Skin Wound Care 18(8): 2-12.
11. Kirsner RS, Orstead H, Wright JB (2001) Matrix metalloproteinases in normal and impaired wound healing: a potential role for nanocrystalline silver. Wounds 13(3 Suppl C): 5-12.
12. Atiyeh BS, Costagliola M, Hayek SN (2007) Dibo S. A. Effect of silver on burn wound infection control and healing: Review of the literature. Burns 33: 139-148.
13. Wright JB, Lam K, Buret AG, Olson ME, Burrell RE (2002) Early healing events in a porcine model of contaminated wounds: effects of nanocrystalline silver on matrix metalloproteinases, cell apoptosis, and healing. Wound Repair Regen 10: 141.
14. Demling RH, DeSanti L (2002) The rate of re-epithelialization across meshed skin grafts is increased with exposure to silver. Burns 28: 264.
15. Lansdown ABG (2002) Silver 2: its antibacterial properties and mechanism of action. J Wound Care 11: 173.
16. Lansdown ABG (2002) "Silver," Parts 1 and 2. J Wound Care 10(125-130): 173-177.
17. Paddock HN, Schultz GS, Perrin KJ, Moldawer LL, Wright B, Burrell RE, Mozingo DW (2002) Clinical assessment of silver-coated antimicrobial dressing on MMPs and cytokine levels in non-healing wounds. Ann. Meeting Presentation. Wound Healing. Society. Baltimore, Md.
18. Poon VK, Burd A (2004) In vitro cytotoxity of silver: implication for clinical wound care. Burns 30: 140-7.
19. Hollinger MA (1996) Toxicological aspects of topical silver pharmaceuticals. Crit Rev Toxicol 26: 255-60.
20. Sawhney CP, Sharma RK, Rao KR, Kaushish R (1989) Long-term experience with 1 percent topical silver sulphadiazine cream in the management of burn wounds. Burns 15: 403-6.
21. Sheridan RL, Petras L, Lydon M et al (1997) Once-daily wound cleansing and dressing change: efficacy and cost. J Burn Care Rehabil 18: 139-40.
22. Klasen HJ (2000) A historical review of the use of silver in the treatment of burns. II. Renewed interest for silver. Burns 26(2): 131-8.
23. Dickinson SJ (1973) Topical therapy of burns in children with silver sulphadiazine. NY State J Med 73: 2045-9.
24. Chaby G, Viseux V, Poulain JF, De Cagny B, Denoeux JP, Lok C (2005) Topical silver sulfadiazine-induced acute renal failure. Ann Dermatol Vénéréol 132(11 Pt 1): 891-3.
25. Rowland-Payne CMR, Bladin C, Colchester ACF (1992) Argyria from excessive use of topical silver sulphadiazine. Lancet 340: 126.
26. Wan AT, Conyers RA, Coombs Cl, Masterton JP (1991) Determination of silver in blood, urine, and tissues of volunteers and burn patients. Clin Chem 37: 1683-7.
27. Dunn K, Edwards-Jones V (2004) The role of Acticoat TM with nanocrystalline silver in the management of burns. Burns 30(Suppl 1): S1-9.
28. Choban PS, Marshall WJ (1987) Leukopenia secondary to silver sulfadiazine: frequency, characteristics and clinical consequences. Am Suurg 53(9): 515-517.
29. Gamelli RL, Paxto TP, O'Reilly M (1993) Bone marrow toxicity by silver sulfadiazine. Surg Gynecol Obstet 177(2): 115-120.